Literature DB >> 9252119

Fc gammaRIIB1 inhibition of BCR-mediated phosphoinositide hydrolysis and Ca2+ mobilization is integrated by CD19 dephosphorylation.

K L Hippen1, A M Buhl, D D'Ambrosio, K Nakamura, C Persin, J C Cambier.   

Abstract

The B cell receptor for immunoglobulin G, Fc gammaRIIB1, is a potent transducer of signals that block antigen-induced B cell activation. Coligation of Fc gammaRIIB1 with B lymphocyte antigen receptors (BCR) causes premature termination of phosphoinositide hydrolysis and Ca2+ mobilization and inhibits proliferation. This inhibitory signal is mediated in part by phosphorylation of Fc gammaRIIB1 and recruitment of phosphatases; however, the molecular target(s) of effectors is unknown. Here we report that Fc gammaRIIB1 inhibition of BCR signaling is mediated in part by selective dephosphorylation of CD19, a BCR accessory molecule and coreceptor. CD19 dephosphorylation leads to failed CD19 association with phosphatidylinositol 3-kinase, and this in turn leads to termination of inositol-1,4,5-trisphosphate production, intracellular Ca2+ release, and Ca2+ influx. The results define a molecular circuit by which Fc gammaRIIB signals block phosphoinositide hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252119     DOI: 10.1016/s1074-7613(00)80509-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  21 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Authors:  T Okazaki; A Maeda; H Nishimura; T Kurosaki; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Visualization of negative signaling in B cells by quantitative confocal microscopy.

Authors:  H Phee; W Rodgers; K M Coggeshall
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 4.  CD19 function in central and peripheral B-cell development.

Authors:  Christopher J Del Nagro; Dennis C Otero; Amy N Anzelon; Sidne A Omori; Ravi V Kolla; Robert C Rickert
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 5.  Regulation of autoreactive anti-IgG (rheumatoid factor) B cells in normal and autoimmune mice.

Authors:  H Wang; M J Schlomchik
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  Inhibition of immunoglobulin E synthesis through Fc gammaRII (CD32) by a mechanism independent of B-cell receptor co-cross-linking.

Authors:  Jutta Horejs-Hoeck; Andrea Hren; Geert C Mudde; Maximilian Woisetschläger
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

7.  Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation.

Authors:  A C Fluckiger; Z Li; R M Kato; M I Wahl; H D Ochs; R Longnecker; J P Kinet; O N Witte; A M Scharenberg; D J Rawlings
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

8.  Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals.

Authors:  A M Scharenberg; O El-Hillal; D A Fruman; L O Beitz; Z Li; S Lin; I Gout; L C Cantley; D J Rawlings; J P Kinet
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

Review 9.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

Review 10.  Calcium signalling and cell-fate choice in B cells.

Authors:  Andrew M Scharenberg; Lisa A Humphries; David J Rawlings
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.